3D bioprinting and its potential impact on cardiac failure treatment: An industry perspective

APL Bioengineering - Tập 4 Số 1 - 2020
Ravi K. Birla1,2, Stuart K. Williams3,4
12Bioficial Organs Program, University of Louisville, Louisville, Kentucky 40202, USA
2BIOLIFE4D 1 , Houston, Texas 77021, USA
31BIOLIFE4D, Houston, Texas 77021, USA
4Bioficial Organs Program, University of Louisville 2 , Louisville, Kentucky 40202, USA

Tóm tắt

3D printing technologies are emerging as a disruptive innovation for the treatment of patients in cardiac failure. The ability to create custom devices, at the point of care, will affect both the diagnosis and treatment of cardiac diseases. The introduction of bioinks containing cells and biomaterials and the development of new computer assisted design and computer assisted manufacturing systems have ushered in a new technology known as 3D bioprinting. Small scale 3D bioprinting has successfully created cardiac tissue microphysiological systems. 3D bioprinting provides an opportunity to evaluate the assembly of specific parts of the heart and most notably heart valves. With the continuous development of instrumentation and bioinks and a complete understanding of cardiac tissue development, it is proposed that 3D bioprinting may permit the assembly of a heart described as a total biofabricated heart.

Từ khóa


Tài liệu tham khảo

2019, Heart disease and stroke statistics—2019 update: A report from the American Heart Association, Circulation, 139, e56, 10.1161/CIR.0000000000000659

2019, The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report—2019; Focus theme: Donor and recipient size match, J. Heart Lung Transplant., 38, 1056, 10.1016/j.healun.2019.08.004

2004, Organ printing: Fiction or science, Biorheology, 41, 371

2016, 3D bioprinting for engineering complex tissues, Biotechnol. Adv., 34, 422, 10.1016/j.biotechadv.2015.12.011

2003, Cell and organ printing 1: Protein and cell printers, Anat. Rec., Part A, 272, 491, 10.1002/ar.a.10057

2004, Three-dimensional bioassembly tool for generating viable tissue-engineered constructs, Tissue Eng., 10, 1566, 10.1089/ten.2004.10.1566

2007, Characterizing environmental factors that impact the viability of tissue-engineered constructs fabricated by a direct-write bioassembly tool, Tissue Eng., 13, 373, 10.1089/ten.2006.0101

2004, Engineering biological structures of prescribed shape using self-assembling multicellular systems, Proc. Natl. Acad. Sci. U. S. A., 101, 2864, 10.1073/pnas.0400164101

2003, Organ printing: Computer-aided jet-based 3D tissue engineering, Trends Biotechnol., 21, 157, 10.1016/S0167-7799(03)00033-7

2014, Introduction to Tissue Engineering: Applications and Challenges, 360

2019, Bioreactors for cardiac tissue engineering, Adv. Healthcare Mater., 8, e1701504, 10.1002/adhm.201701504

2008, Effect of thyroid hormone on the contractility of self-organized heart muscle, In Vitro Cell. Dev. Biol.: Anim., 44, 204, 10.1007/s11626-008-9094-0

2008, Effect of streptomycin on the active force of bioengineered heart muscle in response to controlled stretch, In Vitro Cell. Dev. Biol.: Anim., 44, 253, 10.1007/s11626-008-9114-0

2009, Variable optimization for the formation of three-dimensional self-organized heart muscle, In Vitro Cell. Dev. Biol.: Anim., 45, 592, 10.1007/s11626-009-9234-1

2008, Force characteristics of in vivo tissue-engineered myocardial constructs using varying cell seeding densities, Artif. Organs, 32, 684, 10.1111/j.1525-1594.2008.00591.x

2008, Engineered cardiac organoid chambers: Toward a functional biological model ventricle, Tissue Eng., Part A, 14, 215, 10.1089/tea.2007.0351

2015, Establishing the framework for tissue engineered heart pumps, Cardiovasc. Eng. Technol., 6, 220, 10.1007/s13239-015-0211-4

2018, The bioengineered cardiac left ventricle, ASAIO J., 64, 56, 10.1097/MAT.0000000000000642

2008, Tissue-engineered heart valve prostheses: ‘State of the heart’, Regen. Med., 3, 399, 10.2217/17460751.3.3.399

2008, Bioengineering functional human aortic vascular smooth-muscle strips in vitro, Biotechnol. Appl. Biochem., 50, 155, 10.1042/BA20070139

2015, Establishing the framework for fabrication of a bioartificial heart, ASAIO J., 61, 429, 10.1097/MAT.0000000000000233

2005, The heart: Part one—The anatomy, Nurs. Times, 101, 28

2016, Revisiting the anatomy of the living heart, Circ. J., 80, 24, 10.1253/circj.CJ-15-1147

2005, EC-coupling in normal and failing hearts, Scand. Cardiovasc. J., 39, 13, 10.1080/14017430410004632

2014, Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink, Nat. Commun., 5, 3935, 10.1038/ncomms4935

2015, Establishing the framework to support bioartificial heart fabrication using fibrin-based three-dimensional artificial heart muscle, Artif. Organs, 39, 165, 10.1111/aor.12318

2008, Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart, Nat. Med., 14, 213, 10.1038/nm1684

2013, Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells, Nat. Commun., 4, 2307, 10.1038/ncomms3307

2014, Excitation propagation in three-dimensional engineered hearts using decellularized extracellular matrix, Biomaterials, 35, 7839, 10.1016/j.biomaterials.2014.05.080

2019, 3D printing of personalized thick and perfusable cardiac patches and hearts, Adv. Sci., 6, 1900344, 10.1002/advs.201900344

2016, Application areas of 3D bioprinting, Drug Discovery Today, 21, 1257, 10.1016/j.drudis.2016.04.006

2017, 3D bioprinting for tissue and organ fabrication, Ann. Biomed. Eng., 45, 148, 10.1007/s10439-016-1612-8

2019, Tissue engineering of retina through high resolution 3-dimentional inkjet bioprinting, Biofabrication, 12

2019, Thermal inkjet bioprinting triggers the activation of the VEGF pathway in human microvascular endothelial cells in vitro, Biofabrication, 11, 045005, 10.1088/1758-5090/ab25f9

2017, Single cell isolation process with laser induced forward transfer, J. Biol. Eng., 11, 2, 10.1186/s13036-016-0045-0

2017, Printing functional 3D microdevices by laser-induced forward transfer, Small, 13, 1602553, 10.1002/smll.201602553

2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024

2009, Functional cardiomyocytes derived from human induced pluripotent stem cells, Circ. Res., 104, e30, 10.1161/CIRCRESAHA.108.192237

2013, Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions, Nat. Protoc., 8, 162, 10.1038/nprot.2012.150

2015, Regulation of coronary blood flow in health and ischemic heart disease, Prog. Cardiovasc. Dis., 57, 409, 10.1016/j.pcad.2014.12.002

2015, Effect of sex differences on invasive measures of coronary microvascular dysfunction in patients with angina in the absence of obstructive coronary artery disease, JACC Cardiovasc. interventions, 8, 1433, 10.1016/j.jcin.2015.03.045

2012, Adipose stromal vascular fraction cell construct sustains coronary microvascular function after acute myocardial infarction, Am. J. Physiol. Heart Circ. Physiol., 302, H973, 10.1152/ajpheart.00735.2011

2001, Scaffold-based three-dimensional human fibroblast culture provides a structural matrix that supports angiogenesis in infarcted heart tissue, Circulation, 104, 2063, 10.1161/hc4201.097192

2009, Implantation of a three-dimensional fibroblast matrix improves left ventricular function and blood flow after acute myocardial infarction, Cell Transplant., 18, 283, 10.3727/096368909788535004

2007, Microvascular transplantation after acute myocardial infarction, Tissue Eng., 13, 2871, 10.1089/ten.2007.0025

2013, Adipose-derived cell construct stabilizes heart function and increases microvascular perfusion in an established infarct, Stem Cells Transl. Med., 2, 896, 10.5966/sctm.2013-0046

2011, Direct-write bioprinting three-dimensional biohybrid systems for future regenerative therapies, J. Biomed. Mater. Res. B, 98, 160, 10.1002/jbm.b.31831

1996, Angiogenic potential of microvessel fragments established in three-dimensional collagen gels, In Vitro Cell. Dev. Biol.: Anim., 32, 409, 10.1007/BF02723003

2009, Long-term experience in autologous in vitro endothelialization of infrainguinal ePTFE grafts, J. Vasc. Surg., 49, 352, 10.1016/j.jvs.2008.08.101

2013, Adipose stromal vascular fraction cells isolated using an automated point of care system improve the patency of ePTFE vascular grafts, Tissue Eng., Part A, 19, 1295, 10.1089/ten.tea.2012.0318

2013, Evaluation of cell viability and functionality in vessel-like bioprintable cell-laden tubular channels, J. Biomech. Eng., 135, 91011, 10.1115/1.4024575

2015, Isolation and characterization of embryonic stem cell-derived cardiac Purkinje cells, Stem Cells, 33, 1102, 10.1002/stem.1921

2010, Contactin-2 expression in the cardiac Purkinje fiber network, Circ. Arrhythm Electrophysiol., 3, 186, 10.1161/CIRCEP.109.928820

2015, Efficient generation of cardiac Purkinje cells from ESCs by activating cAMP signaling, Stem Cell Rep., 4, 1089, 10.1016/j.stemcr.2015.04.015

2015, Induced pluripotent stem cell-based therapies for inherited arrhythmias: Opportunities and challenges involved (Review), Mol. Med. Rep., 11, 3, 10.3892/mmr.2014.2668

2013, Sick sinus syndrome: A review, Am. Fam. Physician, 87, 691

2015, Sick sinus syndrome and atrial fibrillation in older persons—A view from the sinoatrial nodal myocyte, J. Mol. Cell. Cardiol., 83, 88, 10.1016/j.yjmcc.2015.02.003

2014, Sick sinus syndrome: A family study, Cardiol. Young, 24, 136, 10.1017/S1047951113000991

2015, Sick sinus syndrome, AACN Adv. Crit. Care, 26, 376, 10.4037/NCI.0000000000000099

2013, 3D bioprinting of heterogeneous aortic valve conduits with alginate/gelatin hydrogels, J. Biomed. Mater. Res., A, 101, 1255, 10.1002/jbm.a.34420

2012, Rapid 3D printing of anatomically accurate and mechanically heterogeneous aortic valve hydrogel scaffolds, Biofabrication, 4, 035005, 10.1088/1758-5082/4/3/035005

2015, Generating patient-specific induced pluripotent stem cells-derived cardiomyocytes for the treatment of cardiac diseases human induced pluripotent stem cell-derived cardiomyocytes: Insights into molecular, cellular, and functional phenotypes, Expert Opin. Biol. Ther., 15, 1399, 10.1517/14712598.2015.1064109

2015, Human induced pluripotent stem cell-derived cardiomyocytes: Insights into molecular, cellular, and functional phenotypes, Circ. Res., 117, 80, 10.1161/CIRCRESAHA.117.305365

2015, Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast, Circ.: Heart Failure, 8, 156, 10.1161/CIRCHEARTFAILURE.114.001317

2015, Generation of cardiac spheres from primate pluripotent stem cells in a small molecule-based 3D system, Biomaterials, 65, 103, 10.1016/j.biomaterials.2015.06.024

2012, Cardiac tissue engineering using tissue printing technology and human cardiac progenitor cells, Biomaterials, 33, 1782, 10.1016/j.biomaterials.2011.11.003

2009, Angiogenesis in a microvascular construct for transplantation depends on the method of chamber circulation, Tissue Eng., Part A, 16, 795

2005, Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells, J. Thorac. Cardiovasc. Surg., 129, 1330, 10.1016/j.jtcvs.2004.12.047

2015, The role of 3D printing in structural heart disease: All that glitters is not gold, JACC Cardiovasc. Imaging, 8, 987, 10.1016/j.jcmg.2015.03.009

2015, Reply: The role of 3D printing in structural heart disease: All that glitters is not gold, JACC Cardiovasc. Imaging, 8, 988, 10.1016/j.jcmg.2015.04.011

2018, Advanced maturation of human cardiac tissue grown from pluripotent stem cells, Nature, 556, 239, 10.1038/s41586-018-0016-3

Thông tin
Thông tin xuất bản

APL Bioengineering

Tập 4 Số 1

Thông tin tác giả